Manoj Medisales Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 1.27%
- Profit Growth 29.23%
- Ebitda 35.70%
- Net Worth 50.92%
- Total Assets 25.86%
About Manoj Medisales
Manoj Medisales Private Limited (MMPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 February 2019 (Five years and 11 months 13 days old ). Its registered office is in Bangalore, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Babulal Bhojani and Rajesh Kumar serve as directors at the Company.
Company Details
-
Location
Bangalore, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909KA2019PTC121562
-
Company No.
121562
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Feb 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Manoj Medisales?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Babulal Bhojani
|
Director | 18-Feb-2019 | Current |
|
Rajesh Kumar
|
Director | 18-Feb-2019 | Current |
Financial Performance of Manoj Medisales.
Manoj Medisales Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.27% increase. The company also saw a substantial improvement in profitability, with a 29.23% increase in profit. The company's net worth Soared by an impressive increase of 50.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Manoj Medisales?
In 2023, Manoj Medisales had a public holding of 55.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Medi365 Limited Liability PartnershipBabulal Bhojani is a mutual person
-
Bhojani Pharma Private Limited
Babulal Bhojani and Rajesh Kumar are mutual person
-
Sp Lifesciences Private Limited
Babulal Bhojani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Manoj Medisales?
Unlock and access historical data on people associated with Manoj Medisales, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manoj Medisales, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manoj Medisales's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.